Varadha Balaji Venkadakrishnan, Instructor at Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, shared a post on X about a paper he co-authored with colleagues published in Cancer Research:
“Excited to share our new study in Cancer Research!
We focus on PROX1 as a key driver of neuroendocrine Prostate Cancer and highlight its potential as a therapeutic target.
Huge thanks to Misha Beltran for her mentorship!”
Title: Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
Authors: Varadha Balaji Venkadakrishnan, Adam Presser, Nathaniel C. E. Voss, James Neiswender, Lisa Brenan, Keira Prenza. Sosa, Kenny Weng, Andres M. Acosta, Francisca Vazquez, Himisha Beltran
You can read the Full Article on Cancer Research.
More posts featuring Varadha Balaji Venkadakrishnan.
